Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.0000-0.3000 (-5.66%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close5.3000
Open5.3800
Bid4.9100 x 900
Ask0.0000 x 800
Day's range4.9400 - 5.3800
52-week range4.9400 - 11.6700
Volume18,227
Avg. volume12,990
Market cap51.166M
Beta (5Y monthly)1.14
PE ratio (TTM)N/A
EPS (TTM)-0.3870
Earnings date23 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.42
  • GlobeNewswire

    Nephros Issues 2022 Shareholder Letter

    SOUTH ORANGE, NJ, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today issued a 2022 letter to shareholders. Dear Shareholder, We are entering 2022 from our strongest position ever. 2021 was our best year to date, slightly exceeding our pre-pandemic revenue. We have retooled our marketing and sales machine to generate and close leads

  • GlobeNewswire

    Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022

    Anticipates Record Full-Year Net Revenue of $10.4 Million, a 21% Year-Over-Year Increase and Fourth Quarter Revenue of $2.8 Million, an 18% Year-Over-Year Increase; Provides 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue SOUTH ORANGE, NJ, Jan. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary re

  • GlobeNewswire

    Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference

    SOUTH ORANGE, NJ, Nov. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros will be attending the Benchmark Company 10th Annual One-on-One Discovery Conference. The conference is taking place virtually on December 2, 2021, in a one-on-one and small group meeting format